RxDoctor Payments DataLook up a doctor →

Andrew Srisuwananukorn, MD

Hematology · Columbus, OHNPI 1033641345

Payments from drug & device makers

$659,201in general payments, 2019–2025

Across 1,443 payments — averaging $456.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Incyte Corporation$350K
  • Sumitomo Pharma America, Inc.$173K
  • Karyopharm Therapeutics Inc.$131K
  • Sobi, Inc$3K
  • Amgen$221
  • Exelixis Inc.$162
  • plus $658 from 7 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$659,201 in reported general payments places this provider in the 65th percentile of 84 hematology providers in Ohio.

See all hematology providers in Ohio

Medicare billing

Part B allowed, 2024
$39,392
Medicare patients
108
Services billed
411

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other hematology in Columbus

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →